Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-10-29
1993-05-04
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530303, A61K 3726, C07K 740
Patent
active
052082172
ABSTRACT:
New insulin analogues have now been synthesized and found to be hepatospecific. These insulin analogues contain substitutions for one
REFERENCES:
patent: 3420810 (1969-01-01), Katsoyannis et al.
patent: 4421685 (1983-12-01), Chance et al.
patent: 4430266 (1984-02-01), Frank
patent: 4459226 (1984-07-01), Grimes et al.
patent: 4569791 (1986-02-01), Frank et al.
patent: 4569792 (1986-02-01), Frank et al.
patent: 4581165 (1986-08-01), Frank et al.
patent: 4652547 (1987-03-01), Chance et al.
patent: 4652548 (1987-03-01), Chance et al.
patent: 4946828 (1990-08-01), Markussen
Chemical Abstracts, vol. 94, p. 623, 94:47733x, Danho et al.
Proc. of the Nat. Acad. of Sciences of the USA 86 (1989) No. 2, pp. 458-4 1.
Ohta et al., J. Protein Chemistry, 7: 55-65 (1988).
Danho, W. et al., Hoppe-Seyler's Z. Physiol. Chemie., 361(5): 747-754, 1980.
Botstein, D. et al., Science, vol. 229, pp. 1193-1201. (1985).
Blake, J. et al., Proc. Natl. Acad. Sci USA 80, pp. 1556-1559 (1986).
Smith, In Vitro Mutagenesis, Annual Review of Genetics, vol. 19, pp. 423-462, (1985).
Chance, R. E., et al. Pept., Proc. Amer, Pept. Symp. 7th., pp. 721-728 (1981).
Katsoyannis, P. G., et al., Journal of the American Chemical Society, 88, 166 (1966).
Kitagawa, K., et al., Biochemistry 23, pp. 1405-1413 4444-4448 (1984).
Schwatz, G. P. et al., Int. J. Peptide Protein Res. 17, pp. 243-255 (1981).
Katsoyannis, P. G. et al., Proceedings of the Natl. Acad. of Sciences, vol. 55, No. 6, pp. 1554-1561 (1966).
Schwartz, G. P. et al., Journal of the Chemical Society, Perkins Transactions I (1973).
Schwartz, G. P. Journal of The Chemical Society, Perkin Transactions I (1973).
Chan S. J., et al., Proc. Natl. Acad., Sci, USA, vol. 84, pp. 2194-2197, (1987).
Katsoyannis, P. G., et al., Biochemistry, v, pp. 2635-2642, 2656-2668 (1967).
Katsoyannis, P. G. et al., Biochemistry, 6, pp. 2642-2655 (1967).
Katsoyannis, P. G. et al., Biochemistry, v. pp. 2656-2668, (1967).
Schwartz, G. et al., Biochemistry, 15, pp. 4071-4076 (1976).
Schwartz et al., J. Chem. Research (M), pp. 2453-2466, (1977).
Schwartz G. P. et al. Journal of Chem. Res. (S) pp. 220-221, (1977).
Katsoyannis, P. G., Structure and Function Relationships In Insulin: A Synthetic Approach, Elsevier North Holland, Inc. pp. 171-192 (1980).
Katsoyannis, P. G., New Synthetic Insulins, Treatment of Early Diabetes, pp. 319-328 (1979).
Burke, G. T. et al. Int. J. Peptide Protein Res., 23, pp. 394-401, (1984).
Schwartz, G., Journal of Protein Chemistry, vol. 1, No. 3, pp. 177-189, (1982).
Ferderigos, N., Int. J. Peptide Protein Res. 13, pp. 43-53, (1979).
Cosmatos, A., et al., Int. J. Peptide Protein Res. 14, pp. 457-471, 1979.
Schwartz, G. et al., Biochemistry, 17, pp. 4550-4556 (1978).
Ferderigos, N., et al. Journal of Protein Chemistry, vol. 2, pp. 147-170, (1983).
Schwartz, G. et al., Biochemistry vol. 22 pp. 4561-4567 (1983).
Field et al., "Role of Liver in Insulin physiology" Diabetes Care 3:255.260 (1980).
Proc. Natl. Acad. Sci, US, vol. 84, Sep. 1987 (US) G. P. Schwartz et al.: "A Superactive insulin": [B10-asparatic Acid] insulin (human), pp. 6408-6411.
Chemical Abstracts, vol. 105, 1986, M. Bajaj et al.: "Coypu insulin. Primary structure, conformation and biological properties of a hystricomorph rodent insulin", see p. 87 abstract No. 184142p.
Chemical Abstracts, vol. 101, 1984, G. T. Burke et al.: "Nature of the B10 amino acid residue. Requirements for high biological activity of insulin" see p. 72, abstract No. 84120d.
Lee Lester L.
Mount Sinai School of Medicine of The City University of New Yor
LandOfFree
Hepatospecific insulin analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatospecific insulin analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatospecific insulin analogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1975244